MCID: THR016
MIFTS: 53

Thrombophlebitis

Categories: Cardiovascular diseases, Blood diseases

Aliases & Classifications for Thrombophlebitis

MalaCards integrated aliases for Thrombophlebitis:

Name: Thrombophlebitis 12 28 51 41 14 69
Phlebitis and Thrombophlebitis of Superficial Vessels of Lower Extremities 12
Thrombophlebitis of Superficial Veins of Lower Extremity 12
Thrombophlebitis of a Superficial Leg Vein Nos 12
Superficial Thrombophlebitis of Leg 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3875
ICD10 32 I80.0
ICD9CM 34 451.0
MeSH 41 D013924
NCIt 46 C3410

Summaries for Thrombophlebitis

Disease Ontology : 12 A phlebitis that results from a blood clot in the vessel.

MalaCards based summary : Thrombophlebitis, also known as phlebitis and thrombophlebitis of superficial vessels of lower extremities, is related to lemierre's syndrome and varicose veins. An important gene associated with Thrombophlebitis is SERPINC1 (Serpin Family C Member 1), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Dalteparin and Heparin have been mentioned in the context of this disorder. Affiliated tissues include lung, bone and heart, and related phenotypes are homeostasis/metabolism and mortality/aging

Wikipedia : 72 Thrombophlebitis is a phlebitis (inflammation of a vein) related to a thrombus (blood... more...

Related Diseases for Thrombophlebitis

Diseases related to Thrombophlebitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 283)
# Related Disease Score Top Affiliating Genes
1 lemierre's syndrome 33.1 MTHFR SERPINE1
2 varicose veins 29.9 F2 F5 MTHFR SERPINC1
3 mesenteric vascular occlusion 29.8 F2 MTHFR
4 protein c deficiency 29.6 F2 F5 MTHFR SERPINC1
5 homocystinuria 29.4 F5 MTHFR SERPINC1
6 factor v deficiency 29.3 F2 F5 F8
7 purpura 29.2 APOH F2 SERPINC1
8 chronic venous insufficiency 29.2 PLAT SERPINE1
9 venous insufficiency 29.1 F2 PLAT SERPINE1
10 factor xii deficiency 29.0 APOH F5 SERPINC1
11 endocarditis 29.0 APOH F2 SERPINC1
12 coronary artery anomaly 29.0 MTHFR PLAT SERPINE1
13 buerger disease 28.8 APOH F2 MTHFR SERPINE1
14 hepatic infarction 28.7 APOH F2 MTHFR SERPINC1
15 arteries, anomalies of 28.4 F2 MTHFR PLAT SERPINC1 SERPINE1
16 vein disease 28.3 F2 F5 F8 MTHFR PLAT SERPINC1
17 antithrombin iii deficiency 28.3 APOH F2 F5 MTHFR SERPINC1
18 protein s deficiency 28.2 APOH F2 F5 MTHFR SERPINC1
19 budd-chiari syndrome 28.2 APOH F2 F5 MTHFR SERPINC1
20 thrombosis 28.2 APOH F2 F5 MTHFR PLAT SERPINC1
21 antiphospholipid syndrome 28.1 APOH F2 F5 MTHFR PLAT SERPINC1
22 pulmonary embolism 27.5 APOH F2 F5 MTHFR PLAT SERPINC1
23 vascular disease 27.4 APOH F5 MTHFR PLAT SERPINC1 SERPINE1
24 thrombophilia due to thrombin defect 27.3 APOH F2 F5 F8 MTHFR PLAT
25 myocardial infarction 27.0 F2 F5 F8 MTHFR PLAT SERPINC1
26 thrombophilia 25.9 APOH F2 F5 F8 MTHFR PLAT
27 thrombophlebitis migrans 12.4
28 femoral vein thrombophlebitis 12.3
29 iliac vein thrombophlebitis 12.1
30 mondor disease 10.9
31 leech infestation 10.4 F2 SERPINC1
32 paracetamol poisoning 10.4 F2 F5
33 anterior spinal artery syndrome 10.4 F2 SERPINC1
34 esophageal varix 10.4 F2 SERPINC1
35 hemoglobin e disease 10.4 F2 F5
36 hypersplenism 10.3 F2 SERPINC1
37 ischemic neuropathy 10.3 F2 MTHFR
38 hemorrhagic fever 10.3 F2 SERPINC1
39 posterior myocardial infarction 10.3 PLAT SERPINC1
40 encephalopathy, familial, with neuroserpin inclusion bodies 10.3 PLAT SERPINC1
41 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 10.3
42 cold urticaria 10.3 SERPINC1 SERPINF2
43 basilar artery occlusion 10.3 F2 PLAT
44 von willebrand disease, type 1 10.3 F2 F8
45 acquired hemophilia a 10.2 F5 F8
46 acquired hemophilia 10.2 F5 F8
47 scott syndrome 10.2 F2 F5
48 factor v and factor viii, combined deficiency of, 2 10.2 F5 F8
49 alcohol-related birth defect 10.2 F2 F8
50 vitamin k deficiency hemorrhagic disease 10.2 F2 F8

Graphical network of the top 20 diseases related to Thrombophlebitis:



Diseases related to Thrombophlebitis

Symptoms & Phenotypes for Thrombophlebitis

MGI Mouse Phenotypes related to Thrombophlebitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.61 APOH F2 F5 F8 MTHFR PLAT
2 mortality/aging MP:0010768 9.23 APOH F2 F5 F8 MTHFR PLAT

Drugs & Therapeutics for Thrombophlebitis

Drugs for Thrombophlebitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 121)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dalteparin Approved Phase 4,Phase 3,Phase 1 9005-49-6
2
Heparin Approved, Investigational Phase 4,Phase 3,Phase 1 9005-49-6 46507594 772
3
Ibuprofen Approved Phase 4 15687-27-1 3672
4
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
5
Etomidate Approved Phase 4 33125-97-2 667484 36339
6
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
7
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
8
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
9 Anticoagulants Phase 4,Phase 3,Phase 1
10 calcium heparin Phase 4,Phase 3,Phase 1
11 Calcium, Dietary Phase 4,Phase 3,Phase 1
12 Fibrinolytic Agents Phase 4,Phase 3,Phase 1
13 Heparin, Low-Molecular-Weight Phase 4,Phase 3,Phase 1
14 Analgesics Phase 4
15 Analgesics, Non-Narcotic Phase 4
16 Anti-Inflammatory Agents Phase 4,Phase 3
17 Anti-Inflammatory Agents, Non-Steroidal Phase 4
18 Antirheumatic Agents Phase 4
19 Cyclooxygenase Inhibitors Phase 4
20 Peripheral Nervous System Agents Phase 4,Phase 3
21 Heparinoids Phase 4,Phase 3
22 Salicylates Phase 4
23 Adjuvants, Anesthesia Phase 4
24 Analgesics, Opioid Phase 4
25 Anesthetics Phase 4
26 Anesthetics, General Phase 4
27 Anesthetics, Intravenous Phase 4
28 Anti-Anxiety Agents Phase 4,Phase 3
29 Central Nervous System Depressants Phase 4,Phase 3
30 GABA Agents Phase 4
31 GABA Modulators Phase 4
32 Hypnotics and Sedatives Phase 4
33 Narcotics Phase 4
34 Neurotransmitter Agents Phase 4,Phase 3
35 Psychotropic Drugs Phase 4,Phase 3
36 Tranquilizing Agents Phase 4,Phase 3
37
Amiodarone Approved, Investigational Phase 3 1951-25-3 2157
38 Fondaparinux Approved, Investigational Phase 3 104993-28-4
39
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
40
Tinzaparin Approved Phase 3 9041-08-1, 9005-49-6 25244225
41
Alizapride Approved Phase 3 59338-93-1 43008
42
Aprepitant Approved, Investigational Phase 3 170729-80-3 6918365 151165
43
Chlorpromazine Approved, Investigational, Vet_approved Phase 3 50-53-3 2726
44
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
45
Dolasetron Approved, Investigational Phase 3 115956-12-2 60654
46
Domperidone Approved, Investigational, Vet_approved Phase 3 57808-66-9 3151
47
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
48
Droperidol Approved, Vet_approved Phase 3 548-73-2 3168
49
Fluphenazine Approved Phase 3 69-23-8 3372
50
Fosaprepitant Approved Phase 3 172673-20-0 219090

Interventional clinical trials:

(show all 31)

# Name Status NCT ID Phase Drugs
1 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Unknown status NCT01245998 Phase 4 Dalteparin;Dalteparin
2 Management of Superficial Thrombophlebitis Completed NCT00264381 Phase 4 Dalteparin sodium injection
3 Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins Completed NCT00377806 Phase 4 Diclofenac gel
4 Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins Completed NCT02346058 Phase 4 Esarin Gel
5 Etomidate vs Propofol-Induction Characteristics Completed NCT02807610 Phase 4 Inj Etomidate;Injection Propofol;Placebo for Propofol
6 Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF Unknown status NCT01817439 Phase 3 Amiodarone
7 Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis Completed NCT01943006 Phase 3 Hirudoid cream 0.3 % Mucopolysaccharide polysulfate;Placebo cream without active substance
8 Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) Completed NCT00443053 Phase 3 Fondaparinux 2.5mg or placebo
9 Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis Completed NCT00362947 Phase 3 LMWH parnaparin subcutaneously
10 Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities Completed NCT00628576 Phase 3 unfractionated heparin;Tinzaparin (Leo)
11 Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) Completed NCT01594749 Phase 3 Fosaprepitant dimeglumine;Fosaprepitant Placebo;Dexamethasone;Ondansetron;Dexamethasone Placebo;Ondansetron Placebo;Rescue Therapy
12 Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) Completed NCT00000517 Phase 3 warfarin
13 Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) Completed NCT00951574 Phase 3 Nadroparin calcium;saline solution (placebo)
14 Efficacy Comparison of Topical and Intravenous Tranexamic Acid to Reduce the Number of Blood Transfusions in TKA Completed NCT01881568 Phase 3 Tranexamic Acid;Tranexamic Acid
15 Homeopathy for Post-operative (C. Section) Recovery Completed NCT00725569 Phase 2, Phase 3 Bellis perennis and Staphysagria (C6);Bellis perennis and Staphysagria (C30);Placebo
16 Progesterone for the Treatment of Traumatic Brain Injury III Terminated NCT00822900 Phase 3 Progesterone;Placebo
17 Treatment for Blood Clots in the Veins of the Legs Completed NCT00001713 Phase 1 Recombinant Tissue Plasminogen Activator;Heparin;Warfarin
18 Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis Completed NCT02070237 Phase 1 Enoxaparin
19 Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies Recruiting NCT01553071 Phase 1 Fenretinide (4-HPR) plus Intravenous Safingol
20 Aromatase Inhibitors for Treatment of Uterine Leiomyomas Withdrawn NCT00945360 Phase 1 Letrozole (aromatase inhibitor)
21 A Complex Contraception Registry Unknown status NCT02219269
22 POST (Prospective Observational Superfial Thrombophlebitis) Completed NCT00818688
23 Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings Completed NCT01793194
24 Trans Radial Versus Transfemoral Route for Coronary Angiography Completed NCT02983721
25 Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins Completed NCT00954980
26 Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency Completed NCT02588911
27 Evaluation of Medical Device Recruiting NCT03329768
28 Ultrasound to Prevent Leg Wound Complications in Heart Bypass. Recruiting NCT02307084
29 Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy Recruiting NCT02890563
30 Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis Terminated NCT01367769
31 A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used. Terminated NCT01840033

Search NIH Clinical Center for Thrombophlebitis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: thrombophlebitis

Genetic Tests for Thrombophlebitis

Genetic tests related to Thrombophlebitis:

# Genetic test Affiliating Genes
1 Thrombophlebitis 28

Anatomical Context for Thrombophlebitis

MalaCards organs/tissues related to Thrombophlebitis:

38
Lung, Bone, Heart, Brain, Liver, Myeloid, Endothelial

Publications for Thrombophlebitis

Articles related to Thrombophlebitis:

(show top 50) (show all 614)
# Title Authors Year
1
Linear morphea masquerading as superficial thrombophlebitis. ( 29334870 )
2018
2
<i>Trichosporon asahii</i> septic thrombophlebitis following lower extremity amputation in an immunocompetent host. ( 29306852 )
2018
3
Pythium Keratitis Leading to Fatal Cavernous Sinus Thrombophlebitis. ( 29319595 )
2018
4
Acute Anorectal Thrombophlebitis Caused by a Protein C Deficiency. ( 29033437 )
2018
5
Necrotizing Lip Infection Causing Septic Thrombophlebitis of the Neck: AA Rare Variant of Lemierre Syndrome. ( 28651067 )
2017
6
Pseudocellulitis Need Not be Benign: Three Cases of Superficial Migratory Thrombophlebitis with "Negative" Venous Duplex Ultrasonography. ( 29399267 )
2017
7
Thrombophlebitis, Septic ( 28613482 )
2017
8
Quantitative T2 mapping for detection and quantification of thrombophlebitis in a rabbit model. ( 27866674 )
2017
9
Risk Factors for Postpartum Septic Pelvic Thrombophlebitis: A Multicenter Cohort. ( 28704844 )
2017
10
Septic thrombophlebitis of the internal jugular vein, a case of Lemierre's syndrome. ( 28580216 )
2017
11
Treatment with dalbavancin in a patient with septic thrombophlebitis of the internal jugular vein due to Staphylococcus aureus after insertion of an implantable cardioverter defibrillator. ( 29132942 )
2017
12
Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin. ( 28626538 )
2017
13
Lesson of the month 1: Spontaneous septic thrombophlebitis presenting with bacteraemia diagnosed by PET-CT scan. ( 28974602 )
2017
14
Dangerous Liaisons: Pelvic Variant of Lemierre Syndrome by Right Common Iliac Vein Thrombophlebitis After Sexual Intercourse. ( 28430681 )
2017
15
Mondor's disease: sclerosing thrombophlebitis of subcutaneous veins in a patient with occult carcinoma of the breast. ( 28572522 )
2017
16
Necrotizing Thrombophlebitis Secondary to Mycobacterium Chelonae in a Hemodialyzed Patient. ( 27415637 )
2016
17
Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. ( 27253585 )
2016
18
Clinical Features and Developing Risks of Saphenous Vein Thrombophlebitis. ( 27375800 )
2016
19
Incomplete BehAset's disease with calf muscle pain and MRI hyperintensity due to possible thrombophlebitis. ( 27748264 )
2016
20
Thrombophlebitis of pinna a rare condition: Role of heparin spray. ( 27746576 )
2016
21
Superficial Thrombophlebitis of the Breast in a Patient with an Arteriovenous Fistula for Hemodialysis. ( 26991444 )
2016
22
The role of anticoagulation in the management of pediatric temporal bone septic thrombophlebitis. ( 26666669 )
2016
23
Thrombophlebitis of cephalic vein in the left forearm related to infliximab infusion. ( 27598885 )
2016
24
What Is the Most Effective Treatment of Superficial Thrombophlebitis? ( 26707361 )
2016
25
Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus. ( 27646586 )
2016
26
Prevalence of Isolated Asymptomatic Deep Vein Thrombosis in Varicose Vein Patients with Superficial Thrombophlebitis: A Single Center Experience in Japan. ( 27087866 )
2016
27
Achromobacter causing a thrombophlebitis and osteomyelitis combination: a rare cause. ( 26347234 )
2015
28
Evaluation and Treatment of Penile Thrombophlebitis (Mondor's Disease). ( 25962547 )
2015
29
Septic thrombophlebitis caused by viridans group Streptococci. ( 25882902 )
2015
30
Postpartum Ovarian Vein Thrombophlebitis with Staphylococcal Bacteremia. ( 26221549 )
2015
31
Does cryostripping add anything to the treatment of the ascending thrombophlebitis of the great saphenous vein? ( 26546597 )
2015
32
Internal jugular vein septic thrombophlebitis (lemierre syndrome) as a complication of pharyngitis. ( 25957375 )
2015
33
Epidemiology and treatment strategies of iliac vein thrombophlebitis. ( 25575974 )
2015
34
Facial vein thrombophlebitis: an uncommon complication of sinusitis. ( 25636529 )
2015
35
Successful Treatment of Dental Infection-Induced Chronic Cavernous Sinus Thrombophlebitis With Antibiotics and Low-Molecular-Weight Heparin: Two Case Reports. ( 26173405 )
2015
36
Superficial thrombophlebitis (superficial venous thrombosis). ( 26099257 )
2015
37
Cavernous sinus thrombophlebitis (sans thrombosis) secondary to odontogenic fascial space infection: an uncommon complication with unusual presentation. ( 25838693 )
2015
38
Streptococcus constellatus Causing Septic Thrombophlebitis of the Right Ovarian Vein with Extension into the Inferior Vena Cava. ( 26171262 )
2015
39
Superficial Vein Thrombophlebitis in a Football Athlete. ( 25961158 )
2015
40
Cerebral venous sinus thrombophlebitis as a complication of acute otitis media. ( 25440866 )
2015
41
Low-level laser therapy for the treatment of superficial thrombophlebitis after chemotherapy in breast cancer patients: a case study. ( 26834384 )
2015
42
Thrombophlebitis of the temporal vein as an extracranial complication of acute bacterial rhinosinusitis. ( 26322458 )
2015
43
Intestinal Infarction Caused by Thrombophlebitis of the Portomesenteric Veins as a Complication of Acute Gangrenous Appendicitis After Appendectomy: A Case Report. ( 26091450 )
2015
44
Diagnosis of Brachiocephalic Thrombophlebitis as the Cause of Fever of Unknown Origin by 18F-FDG-PET/CT. ( 25800595 )
2015
45
Treatment for superficial infusion thrombophlebitis of the upper extremity. ( 26588711 )
2015
46
A Case of IgG4-Related Disease Presenting as Massive Pleural Effusion and Thrombophlebitis. ( 24851132 )
2014
47
Rivaroxaban as an effective treatment for recurrent superficial thrombophlebitis related to primary antiphospholipid syndrome. ( 25186062 )
2014
48
Ovarian Vein Thrombophlebitis Related to Large Uterine Myoma. ( 24413242 )
2014
49
Migratory superficial thrombophlebitis in a cannabis smoker. ( 25001627 )
2014
50
Treatment of lower extremity superficial thrombophlebitis. ( 24549553 )
2014

Variations for Thrombophlebitis

Expression for Thrombophlebitis

Search GEO for disease gene expression data for Thrombophlebitis.

Pathways for Thrombophlebitis

GO Terms for Thrombophlebitis

Cellular components related to Thrombophlebitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.88 APOH F2 PLAT SERPINC1 SERPINE1 SERPINF2
2 extracellular region GO:0005576 9.76 APOH F2 F5 F8 PLAT SERPINC1
3 endoplasmic reticulum lumen GO:0005788 9.56 F2 F5 F8 SERPINC1
4 blood microparticle GO:0072562 9.54 F2 SERPINC1 SERPINF2
5 COPII-coated ER to Golgi transport vesicle GO:0030134 9.32 F5 F8
6 platelet alpha granule lumen GO:0031093 9.26 F5 F8 SERPINE1 SERPINF2
7 extracellular space GO:0005615 9.23 APOH F2 F5 F8 PLAT SERPINC1

Biological processes related to Thrombophlebitis according to GeneCards Suite gene sharing:

(show all 19)
# Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.75 F2 F5 SERPINC1
2 ER to Golgi vesicle-mediated transport GO:0006888 9.72 F2 F5 F8
3 blood coagulation GO:0007596 9.72 F2 F5 F8 PLAT SERPINC1
4 negative regulation of endopeptidase activity GO:0010951 9.7 SERPINC1 SERPINE1 SERPINF2
5 negative regulation of peptidase activity GO:0010466 9.69 SERPINC1 SERPINE1 SERPINF2
6 acute-phase response GO:0006953 9.63 F2 F8 SERPINF2
7 regulation of blood coagulation GO:0030193 9.61 APOH F2 SERPINC1
8 blood circulation GO:0008015 9.58 F5 MTHFR
9 blood coagulation, intrinsic pathway GO:0007597 9.58 APOH F2 F8
10 negative regulation of proteolysis GO:0045861 9.57 F2 PLAT
11 positive regulation of collagen biosynthetic process GO:0032967 9.56 F2 SERPINF2
12 hemostasis GO:0007599 9.56 F2 F5 F8 SERPINC1
13 platelet degranulation GO:0002576 9.55 APOH F5 F8 SERPINE1 SERPINF2
14 negative regulation of blood coagulation GO:0030195 9.54 APOH SERPINE1
15 positive regulation of blood coagulation GO:0030194 9.54 APOH F2 SERPINE1
16 plasminogen activation GO:0031639 9.49 APOH PLAT
17 negative regulation of plasminogen activation GO:0010757 9.48 SERPINE1 SERPINF2
18 fibrinolysis GO:0042730 9.26 F2 PLAT SERPINE1 SERPINF2
19 negative regulation of fibrinolysis GO:0051918 8.92 APOH F2 SERPINE1 SERPINF2

Molecular functions related to Thrombophlebitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 heparin binding GO:0008201 9.43 APOH F2 SERPINC1
2 peptidase inhibitor activity GO:0030414 9.33 SERPINC1 SERPINE1 SERPINF2
3 protease binding GO:0002020 9.13 SERPINC1 SERPINE1 SERPINF2
4 serine-type endopeptidase inhibitor activity GO:0004867 8.8 SERPINC1 SERPINE1 SERPINF2

Sources for Thrombophlebitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....